AZ’ lung cancer drug Tagrisso backed for first-line use
European regulatory advisors are supporting approval of AstraZeneca’s lung cancer drug Tagrisso in the first-line setting.
Read More
Tag: dasatinib
Leukaemia drug shows promise in ovarian cancer
A drug approved for leukaemia has also shown promise in treating a specific type of ovarian cancer in a Cancer Research UK-funded study published in the journal Molecular Cancer Therapeutics.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
